ABY:NSD-Abengoa Yield Plc (USD)

COMMON STOCK | Other | NSD

Last Closing Price

USD 16.60

Change

+0.10 (+0.61)%

Market Cap

USD 2.36B

Volume

0.01M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Atlantica Yield plc acquires, owns, and manages renewable energy, conventional power, electric transmission lines and water assets in North America, South America, Spain, Algeria, and South Africa. As of December 31, 2016, it had 21 contracted assets, including 1,442 megawatts (MW) of renewable generation assets comprising solar power and wind plants; 300 MW of conventional power generation assets that produce electricity and steam from natural gas; 1,099 miles of electric transmission lines; and desalination plants with an aggregate capacity of 10.5 million cubic feet per day. The company was formerly known as Abengoa Yield plc and changed its name to Atlantica Yield plc in May 2016. Atlantica Yield plc was incorporated in 2013 and is based in Brentford, the United Kingdom.

Employees : 166

Currency: USD

Country : USA

Technical Indicators

Beta : 1.12

52 Week High : 0.47

Short Ratio : 2.00

52 Week Low : 16.76

Shorted Shares : 715,874

200 Day Moving Average : 20.61

50 Day Moving Average : 21.10

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-17 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LGCY Legacy Reserves Inc

N/A

 USD61,525,874.67B 1.10 5.30
FTD FTD Companies, Inc

N/A

 USD28,725,913.80B N/A N/A
KEYW The KeyW Holding Corporation

N/A

 USD24,651,104.38B 166.80 24.48
SNHY Helios Technologies, Inc

N/A

 USD17,848,852.22B 1,000,000.00 N/A
QTNA Quantenna Communications, Inc

N/A

 USD8,997,243.52B 175.07 79.98
INSY INSYS Therapeutics, Inc

N/A

 USD4,995,459.82B 115.90 N/A
CHKE Apex Global Brands Inc

N/A

 USD384,202.91B 17.30 N/A
AMCN AirNet Technology Inc

N/A

 USD308,457.30B 1.00 N/A
PDVW pdvWireless, Inc

N/A

 USD95,944.74B N/A N/A
AIPT Predictive Oncology Inc

N/A

 USD38,513.36B N/A N/A

ETFs Containing ABY

Symbol Name Weight Mer Price(Change) Market Cap
IPU SPDR(R) S&P(R) INTERNATIO.. 0.00 % 0.00 %

N/A

 USD0.02B

Market Performance

  Market Performance vs.
Industry/Classification (Other)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -14.17% 38% F 39% F
Dividend Return -6.70% 20% F N/A N/A
Total Return -20.87% 38% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 6.01% N/A N/A N/A N/A
Dividend Return 1.20% N/A N/A N/A N/A
Total Return 7.21% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.10% N/A N/A N/A N/A
Risk Adjusted Return 34.17% N/A N/A N/A N/A
Market Capitalization 2.36B 89% B+ 80% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Other)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 75.70 11% F 15% F
Price/Book Ratio 18.78 10% F 6% F
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 2.73% 67% D+ 53% F
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio 292.19% 8% F 6% F
Technical Ratios  
Short Ratio 2.00 50% F 63% D
Short Percent 120.00% 25% F 3% F
Beta 1.12 30% F 50% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.